Upstart vs. Pagaya Technologies: Which Financial Stock Is a Better Buy in 2026?

Upstart and Pagaya both posted strong FY 2025 results, with revenue of about $1.1B and $1.3B, respectively. Upstart grew revenue 58.9% but had nearly -$166.1M free cash flow and higher leverage at 2.3x debt-to-equity, while Pagaya delivered $81.4M net income, 6.5% net margin, and $224.7M free cash flow with lower leverage at 1.9x. The article’s conclusion favors Pagaya as the more balanced AI-lending investment, though both remain exposed to consumer credit and rates.

Analysis

The market is starting to separate AI lending into two very different business models: one that monetizes underwriting intelligence directly, and one that monetizes workflow infrastructure and takes less balance-sheet risk. That distinction matters because in a tightening or late-cycle credit environment, the lower-capital-intensity model should re-rate first, even if headline growth is slower. On that basis, the cleaner trade is not “AI lending” broadly, but quality within the stack: favor the name with better cash generation and less reliance on warehouse/funding markets over the higher-beta platform that still behaves partly like a lender.

The second-order effect is on incumbents, especially FICO. If alternative scoring keeps gaining share, the pricing power of traditional bureau-adjacent underwriting tools becomes more vulnerable at the margin, but adoption will likely be uneven and partner-driven rather than a sudden displacement. That means this is more of a slow-burn share shift than an immediate secular break, with the real winner being lenders that can A/B test multiple models and switch between them based on cycle conditions.

The key risk over the next 3-6 months is not model quality in isolation; it is credit normalization. If unemployment or delinquencies tick up, the higher-concentration platforms will see partner caution first, and any funding disruption would hit the more balance-sheet-dependent model fastest. Conversely, if rates drift lower and origination volume re-accelerates, the more levered name can outperform sharply, but that upside is contingent on a benign macro tape rather than just better execution.

Consensus seems to be underestimating how much of the current appeal is already in the valuation spread. The cheaper name looks optically attractive, but the market is pricing in its lower capital burn and steadier cash conversion; the more interesting opportunity may be in owning the structurally better risk-adjusted compounder and fading the idea that all AI-fintech upside is created equal. In other words, this is a relative-value story disguised as a thematic growth story.

Key Decisions for Investors

• Long PGY / short UPST as a 3-6 month relative-value pair: favor the asset-light model with stronger free-cash-flow conversion; target a 15-20% spread capture if credit conditions stay mixed.
• Avoid initiating a fresh outright long in UPST until there is evidence of sustained origination acceleration or easing funding conditions; downside could re-open quickly if delinquencies or partner caution rise over the next 1-2 quarters.
• Use any 10-15% pullback in PGY to build a starter long position for a 6-12 month horizon; risk/reward improves if the market continues rewarding capital-light fintech with balance-sheet discipline.
• Hedge the AI-credit theme by pairing a long in the stronger operator with a small short in FICO over 6-12 months if alternative underwriting adoption keeps broadening; this is a slow-burn share-shift trade, not a catalyst-driven squeeze.
• For event-driven exposure, consider call spreads on UPST only if rates roll over and consumer credit remains stable for another quarter; otherwise the payoff is dominated by macro, not company-specific upside.